Ejemplo: Heart Attack

Buscar ensayos clínicos para: Radiation-Protective Agents

Total 455 resultados

NCT02729324

Estado desconocido

Comparison of Efficacy and Safety Between Medical Radiation Protectants (FORRAD®) and Trolamine (Biafine) for the Management of Radiation Dermatitis in Patients With Nasopharyngeal Carcinoma Receiving IMRT

Condiciones: Nasopharyngeal Neoplasms; Radiodermatitis
NCT00003583

Estado desconocido

Amifostine to Prevent Side Effects in Patients Who Are Receiving Chemotherapy and Radiation Therapy for Limited-Stage Small Cell Lung Cancer

Condiciones: Drug/Agent Toxicity by Tissue/Organ; Lung Cancer; Radiation Toxicity
NCT00167908

Completado

Study of Amifostine and IMRT for Protecting Salivary Glands in Head and Neck Cancer

Condiciones: Head and Neck Cancer
NCT01762514

Estado desconocido

A Phase II Clinical Trial on Comparison of Effectiveness and Safeness of Different Amifostine Regimens

Condiciones: Nasopharyngeal Neoplasms; Salivary Gland Diseases; Bone Marrow Diseases; Mucositis
NCT01586117

Estado desconocido

A Phase II Study of Amifostine for the Prevention of Acute Radiation-Induced Rectal Toxicity

Condiciones: Rectal Cancer
NCT01364259

Terminado

A Study of Amifostine for Prevention of Facial Numbness in Radiosurgery Treatment of Trigeminal Neuralgia

Condiciones: Trigeminal Neuralgia
NCT01288625

Suspendido

Prospective Study of Head and Neck Cancer Radiation Treatment With or Without Amifostine

Condiciones: Oral Mucositis; Stomatitis
NCT00137358

Retirado

Radiation With Chemotherapy and a Study Drug to the Para-Aortic Nodes in Cervical Cancer

Condiciones: Cervical Cancer
NCT00003252

Completado

Amifostine in Treating Patients With Cancer Who Have Neurological Changes Caused by Chemotherapy

Condiciones: Drug/Agent Toxicity by Tissue/Organ; Unspecified Adult Solid Tumor, Protocol Specific
NCT00503776

Terminado

Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia

Condiciones: Dysphagia; Head and Neck Cancer; Mucositis; Xerostomia
NCT00409331

Terminado

Amifostine With IMRT for Submandibular and Sublingual Salivary Sparing During Head and Neck Cancer Treatment

Condiciones: Head and Neck Cancer
NCT00158691

Completado

Intravenous Versus Subcutaneous Amifostine in Prevention of Xerostomia After RT for Head and Neck Carcinomas

Condiciones: Head and Neck Cancer
NCT00158041

Completado

Subcutaneous Amifostine Safety Study

Condiciones: Head and Neck Cancer; Lung Cancer; Lymphoma
NCT00130143

Completado

Toxicities Associated With Subcutaneous Administration of Ethyol (Amifostine) for the Prevention of Radiation-Induced Toxicities

Condiciones: Head and Neck Cancer; Lung Cancer
NCT00136474

Completado

Amifostine for Head and Neck Irradiation in Lymphoma

Condiciones: Lymphoma; Hodgkin's Disease; Non-Hodgkin's Lymphoma
NCT00098683

Completado

Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes

Condiciones: Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms
NCT00003580

Completado

Amifostine to Treat Side Effects of Treatment in Patients Receiving Radiation Therapy and Cisplatin for Advanced Head and Neck Cancer

Condiciones: Drug/Agent Toxicity by Tissue/Organ; Head and Neck Cancer; Oral Complications; Radiation Toxicity
NCT00086099

Completado

Study Evaluating the Addition of Amifostine (Ethyol®) to Idarubicin and Cytosine Arabinoside in Older Patients With Acute Myeloid Leukemia

Condiciones: Leukemia; Acute Myeloid Leukemia
NCT00003048

Completado

Amifostine in Treating Patients With Myelodysplastic Syndrome

Condiciones: Myelodysplastic Syndromes
NCT00003143

Completado

Combination Chemotherapy With or Without Amifostine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Disease Undergoing Stem Cell Transplantation

Condiciones: Lymphoma
NCT00003123

Estado desconocido

Amifostine in Treating Patients With Advanced Myelodysplastic Syndrome

Condiciones: Myelodysplastic Syndromes
NCT00081315

Completado

Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer

Condiciones: Esophagitis; Pneumonitis; Non-Small Cell Lung Carcinoma
NCT00078845

Completado

Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors

Condiciones: Breast Cancer; Lung Cancer; Neurotoxicity; Ovarian Cancer; Prostate Cancer; Unspecified Adult Solid Tumor, Protocol Specific
NCT00286611

Completado

Determination of Amifostine Levels During Radiation Therapy

Condiciones: Cancer
NCT00003307

Completado

Radiation Therapy Plus Amifostine in Treating Patients With Primary Prostate Cancer

Condiciones: Prostate Cancer; Radiation Toxicity